Women's Fem Dophilus

Adult Female (18 - 50 Years) Gluten Free NP ORAL PROBIOTIC SUPPLEMENT 04214FEM60 PROD # 103030 25+ YEARS OF RESEARCH/CLINICAL STUDIES Made in Denmark by Chr. Hansen A/S Martinez, et al. Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1(R), and Lactobacillus reuteri RC-14(R) : a randomized, double-blind, placebo-controlled trial. Can J Microbiol 2009;55:133-138 {chart} 25+ YEARS OF GR-1(R)/ RC-14(R) RESEARCH / CLINICAL STUDIES Fem-Dophilus(R) Introduced (2006) 1988 1994 2000 2006 2012 2014 1988-First Research on GR-1(R)/RC-14(R) Strains Begin -27 Clinical Studies Published Between 2001 and 2014 Under license from Chr. Hansen A/S and protected by Chr. Hansen A/S patents of the WO 00/35465 patent family, and others. VAGINAL/URINARY TRACT HEALTH 02514FEM60 PROD # 103030 Keep refrigerated. GLUTEN FREE 5 Billion viable cells per capsule when kept refrigerated and within Best Used Before Date. Suggested Use: For maintenance, take 1 capsule orally per day and increase to 2 capsules per day as needed or take as directed by your qualified healthcare professional.

Contains: Dairy (casein, in trace amounts). Fem-Dophilus(R) contains two patented and clinically documented probiotic strains, Lactobacillus rhamnosus, GR-1(R) and Lactobacillus reuteri, RC-14(R), discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. PATENTED STRAINS LACTOBACILLUS RHAMNOSUS GR-1(R) and LACTOBACILLUS REUTERI RC-14(R) No wheat, no gluten, no soybeans, no egg, no fish/shellfish, no peanuts/tree nuts.

Contains: Dairy (casein, in trace amounts). Keep out of reach of children.